Is Clio Korean? Who Owns the Korean Makeup Company Behind Peripera and Goodal
Yes, Clio is Korean. Clio Cosmetics (클리오) is a Seoul KOSDAQ company whose founder, Han Hyun-ok, owns 48.57%. Its Q3 2026 filing shows nine-month operating profit of ₩25.1bn, already above all of 2025, even as sales and exports slipped.

From Clio on Amazon: CLIO Kill Cover Founwear Cushion, the 20-shade export versionAffiliate link. As an Amazon Associate, EpicKor earns from qualifying purchases at no extra cost to you.
Quick Answer
Is Clio Korean? Yes. CLIO is a Korean makeup brand owned by Clio Cosmetics Co., Ltd. (주식회사 클리오), a company headquartered at 66 Wangsimni-ro, Seongdong-gu, Seoul, and listed on Korea's KOSDAQ market (ticker 237880) since 9 November 2016. Its filings describe the business as descending from Clio Sangsa (클리오 상사), set up in 1993 as what the company calls Korea's first colour-makeup brand. The present company was incorporated on 31 May 1997.
Who owns Clio Cosmetics? Its founder and CEO, Han Hyun-ok (한현옥). She owns 8,777,940 shares, or 48.57%. With her child and spouse, the family held 60.71% on 31 December 2025, according to the FY2025 annual report filed on DART on 23 March 2026, and 62.06% by June 2026 after her child bought more shares on the market. Clio is a founder-controlled, mid-sized listed company. It is not part of Amorepacific, LG or any other conglomerate.
Which brands does it own? The colour brands CLIO and peripera (페리페라), the skincare brands Goodal (구달) and DERMATORY (더마토리), the hair-care brand Healing Bird (힐링버드), the body and scent brand TYPE NUMBER (타입넘버) and the supplement brand TRUE RX (트루알엑스). Kill Cover (cushions) and Kill Brow (brow pencils) are product lines inside the CLIO brand, not separate companies.
Where is it made? In Korea, by contract manufacturers. Clio owns no factory. Its largest supplier is COSMAX (코스맥스).
How is it doing? Sales are flat to slightly down, but profit has jumped. For January to September 2026, consolidated revenue was ₩245.4 billion (about $184 million), down 1.2% on a year earlier, while operating profit was ₩25.1 billion (about $19 million), up 167% and already more than the whole of 2025 (₩16.4 billion).
This is a public-information company spotlight. EpicKor has no relationship with Clio Cosmetics, and nothing here is investment advice. Won figures come from the company's DART filings unless a press source is named. Dollar figures apply a single rate, ₩1,335 to the dollar (the Bank of Korea's rate on 17 November 2026), to every period, for reference only; they are not period-average conversions, and they are rounded.
Quick Guide: Clio Cosmetics At A Glance
| Item | Detail | Source |
|---|---|---|
| Official name | Clio Cosmetics Co., Ltd. (주식회사 클리오) | Q3 2026 report |
| Roots | Clio Sangsa (클리오 상사), founded 1993. Current company incorporated 31 May 1997 | Q3 2026 report |
| Head office | 66 Wangsimni-ro, Seongdong-gu, Seoul | Q3 2026 report |
| Founder and CEO | Han Hyun-ok (한현옥), CEO since October 1993 | FY2025 annual report |
| Listed | KOSDAQ, 9 November 2016, ticker 237880. 18,071,353 shares | Q3 2026 report |
| Largest shareholder | Han Hyun-ok, 48.57%. Family total 60.71% (31 Dec 2025), 62.06% (June 2026) | FY2025 annual report; large-holding report, 29 June 2026 |
| Main brands | CLIO, peripera, Goodal, DERMATORY, Healing Bird, TYPE NUMBER, TRUE RX | Q3 2026 report |
| Factories | None. Made by COSMAX, C&C International, Kolmar Korea and others | Q3 2026 report |
| 2025 revenue | ₩328.9 billion (about $246 million), operating profit ₩16.4 billion | Q3 2026 report, summary financials |
| Jan–Sep 2026 | Revenue ₩245.4 billion, operating profit ₩25.1 billion | Q3 2026 report |
| Domestic vs export | 59% domestic, 41% export (Jan–Sep 2026) | Q3 2026 report |
| Product mix | Eye makeup 33%, skincare 26%, base makeup 23%, lip 16% | Q3 2026 report |
CLIO Kill Cover Founwear Cushion — the product most people mean when they say "Clio" If you came here to check that CLIO is a genuine Korean brand before buying its best-known cushion, this is the export version sold in 20 shades, against the five shades on Clio's own Korean store set. Base makeup, the category the cushion belongs to, was 23% of Clio's sales in 2026 so far. Check the current price on the listing. As an Amazon Associate, EpicKor earns from qualifying purchases at no extra cost to you.
See CLIO Kill Cover Founwear Cushion on AmazonWhy People Ask Whether Clio Is Korean
The question is fair. "Clio" sounds Greek or French (Clio is the Greek muse of history), and nothing in the name points to Korea. There is also a long-running French car called the Renault Clio, which crowds search results.
The Korean paperwork does. Clio's Q3 2026 quarterly report, filed on DART on 13 November 2026, opens its business section like this: "클리오는 ... 1993년 설립된 국내 최초 색조 브랜드인 클리오 상사를 전신으로 하며". In English: Clio's predecessor is Clio Sangsa, founded in 1993 as Korea's first colour-makeup brand. "First" is the company's own claim. What the filing proves is the rest: a Korean company, Korean management, Korean shareholders and Korean contract factories.
The company's English site states its aim as "EVERY POUCH ONE CLIO", one Clio product in every makeup pouch. That fits the business model: lots of affordable, fast-changing makeup sold in very high volume.
Who Owns Clio Cosmetics
Clio is founder-run. Han Hyun-ok has been CEO since October 1993, and the FY2025 annual report states that the largest shareholder has not changed since the company was founded ("당사의 설립일부터 공시작성기준일 현재까지 최대주주의 변동은 없습니다").
The annual report's table of the largest shareholder and related parties (최대주주 및 특수관계인의 주식소유 현황), dated 31 December 2025 and filed on 23 March 2026, reads:
| Shareholder | Relationship (as filed) | Shares | Stake |
|---|---|---|---|
| Han Hyun-ok (한현옥) | Largest shareholder (최대주주 본인) | 8,777,940 | 48.57% |
| Hong Myung-ha (홍명하) | Child of the largest shareholder (최대주주의 자녀) | 2,135,000 | 11.81% |
| Hong Seok-ki (홍석기) | Spouse of the largest shareholder (최대주주의 배우자) | 59,000 | 0.33% |
| Total | 10,971,940 | 60.71% |
Out of 18,071,353 shares, the same report counts 19,649 small shareholders holding 35.05%.
So is it 48.57% or 60.71%? Both are correct; they measure different things. 48.57% is the founder's own stake. 60.71% is the founder plus her child and spouse at the end of 2025. Hankyung reported the same split in May 2025: "한현옥 대표(지분 48.57%) 외 특수관계인 2인이 지분 60.71%를 보유한 최대주주".
It has gone up since. In a large-holding report (주식등의대량보유상황보고서) filed on 29 June 2026, the family's combined stake rose to 11,214,910 shares, or 62.06%. The stated reason was on-market purchases by Hong Myung-ha (특별관계자(홍명하)의 장내매수): 242,970 shares bought in 23 trades between 20 February and 24 June 2026, at prices between ₩9,991 and ₩13,565 a share. The report gives the funding as ₩2.94 billion (about $2.2 million) of the buyer's own money, sourced from "근로소득 등" (employment income and other sources). The Q3 2026 report confirms the position on 30 September 2026: Han 48.57%, Hong Myung-ha 13.16%, Hong Seok-ki 0.33%, treasury shares 3.03% and other shareholders 34.92%.
The same June filing discloses a pledge. Since 27 February 2019, 600,000 of Hong Myung-ha's shares had been pledged to the Gangnam tax office (강남세무서) as security. The filing explains that the pledge covered gift tax paid in annual instalments (증여세 ... 연부연납), and that it was released once the instalments were completed. The filing does not say who gave what. But a pledge to the tax office for gift-tax instalments suggests that at least part of the child's stake was received as a gift, and that the tax on it has now been paid off. That is EpicKor's inference from the filing, not a statement in it. Clio has not announced any succession plan, and the filings do not say Hong Myung-ha holds a management role; the annual report's list of executives does not include that name.
Family control has two consequences:
- Nobody can outvote the founder. With more than 60% in family hands, shareholder votes are a formality. Dealsite reported in 2022 that the National Pension Service had voted against re-electing Clio's outside director at the 2021 meeting because of low attendance; Dealsite put her attendance over her tenure at 66% (57 of 86 board meetings). It said she was re-elected anyway, because the family held more than 66% of the shares at the time, and that the NPS had also voted against re-electing the company's auditor in 2022. The FY2025 annual report says the board is made up of three inside directors, with Han as chair and no separate board committees.
- The free float is small. Hankyung estimated in May 2025 that once the family, treasury shares and a few institutions were excluded, "실제 유통 물량은 25%가 조금 넘는다", meaning just over a quarter of the shares actually trade.
Dividends. Clio pays a yearly cash dividend. For 2025 it declared ₩250 a share (₩4.38 billion in total) on 13 February 2026, down from ₩400 for 2024 after the weak year. On the 60.71% the family held at the record date, about ₩2.7 billion of that went to the family; that split is EpicKor's arithmetic.
Who Is Han Hyun-ok?
The annual report's executive table gives a short career history. Han Hyun-ok, born in April 1960, studied sociology at Yonsei University and its graduate school (1978–1984), worked at the Korea Institute of Science and Technology (KIST) from 1984 to 1985, founded a market-research firm, Hyundai Research Institute (현대리서치연구소), in 1987, then founded Société Beauté (쏘시에떼 보떼) in 1992 before becoming CEO of Clio in October 1993.
In a 2012 interview with the Korean magazine Sidae, she described the start as a reaction to timing. After Korea liberalised cosmetics imports, foreign colour brands "such as Bobbi Brown" were just arriving, and she decided to compete with a brand of her own rather than one that paid royalties abroad: "로열티를 내는 해외 브랜드보다 자체 브랜드로 뛰어보자는 판단이 섰었죠." Clio stayed a makeup specialist for most of its history. Skincare (Goodal), hair and body care, and supplements came much later; Hankyung reported that the supplement brand TRUE RX has been sold through the subsidiary Clio Lifecare (클리오라이프케어) since April 2021.
One episode shows how the company adapts. Clio used to run its own branded road shops, Club Clio (클럽클리오). As multi-brand stores such as Olive Young took over Korean high streets, it closed them; the company told Dealsite in 2022 that all the Club Clio stores had been withdrawn by the first half of that year. The name lives on as Clio's official online store.
How Clio Makes Money
Clio is a brand-and-marketing company. It designs products, picks colours and formulas, briefs factories and sells, but it does not make anything. The Q3 2026 report says in three separate places: "당사는 자체 생산설비 없이 외주가공 형태로 제품을 생산하고 있으므로 해당사항이 없습니다" (the company produces through outsourced manufacturing without its own facilities, so this does not apply).
What it sells
The report breaks sales down by category:
| Category | 2024 | 2025 | Jan–Sep 2026 |
|---|---|---|---|
| Eye makeup | ₩94.8bn (27.0%) | ₩95.4bn (29.0%) | ₩81.4bn (33.2%) |
| Skincare | ₩93.3bn (26.6%) | ₩83.2bn (25.3%) | ₩63.1bn (25.7%) |
| Base makeup | ₩84.8bn (24.1%) | ₩82.2bn (25.0%) | ₩55.6bn (22.6%) |
| Lip makeup | ₩72.2bn (20.6%) | ₩59.3bn (18.0%) | ₩40.1bn (16.4%) |
| Other | ₩6.2bn (1.8%) | ₩8.8bn (2.7%) | ₩5.2bn (2.1%) |
| Total | ₩351.4bn | ₩328.9bn | ₩245.4bn |
Eye makeup is now the biggest category. CLIO's best-known eye products include the Pro Eye Palette and its mascaras, and Cosin Korea reported that Clio's North American growth in Q2 2026 came from strong sales in Amazon's eye category. And lip is shrinking, from ₩72.2 billion in 2024 to a run rate well below that in 2026. Lip tints are peripera's core, so the lip decline falls largely on that brand's category.
By brand, Hankyung reported that CLIO was 49% of 2024 sales and peripera 24%. The rest is Goodal, DERMATORY and the smaller lines.

What a typical sale is worth
The report includes an unusual number: average revenue per unit sold. In 2025 it was ₩6,982 per item at home and ₩6,873 (about $5) for exports; for January to September 2026 it was ₩7,411 at home and ₩5,989 (about $4.50) for exports. These are company-wide averages, not shelf prices. Clio sells cheap items in enormous numbers, and the company calls its market "패스트 코스메틱", fast cosmetics.
Who makes it
The report lists its top five suppliers by purchases. For January to September 2026:
| Supplier | Purchases, Jan–Sep 2026 | Average unit cost |
|---|---|---|
| COSMAX (코스맥스) | ₩61.7 billion | ₩3,472 |
| C&C International (씨앤씨인터내셔널) | ₩15.3 billion | ₩2,004 |
| Kolmar Korea (한국콜마) | ₩11.0 billion | ₩3,224 |
| Intercos Korea (인터코스코리아) | ₩6.2 billion | ₩6,889 |
| COCO (코코) | ₩5.8 billion | ₩1,518 |
COSMAX alone supplied more than four times as much as the next maker. If you want to understand the factory side of K-beauty, our COSMAX deep dive covers the company that makes a large share of Clio's products. C&C International is a lip and point-makeup specialist, which fits peripera's tint-heavy range.
Where It Sells: Olive Young First
Clio's report lists five sales routes: exports, online (its own mall and online agents), duty-free, H&B stores and home shopping. H&B means health-and-beauty chains, and in Korea that mostly means CJ Olive Young (CJ올리브영).
How dependent is Clio on that one chain? The filing gives a clue without naming names. In the notes to its separate financial statements, Clio says that one customer accounted for more than 10% of its revenue, with sales of ₩90.4 billion (about $68 million) in January to September 2026, up from ₩82.6 billion a year earlier. On ₩235.9 billion of separate revenue, that one customer is 38% of the business, up from 34%.
The filing does not say who the customer is. Olive Young is the dominant health-and-beauty chain in Korea and Clio's main domestic channel, so it is very likely Olive Young, but that is EpicKor's inference, not the filing's. What is on record is how big Clio is inside Olive Young: CJ Olive Young's newsroom said in February 2024 that CLIO and Round Lab were the first small and mid-sized brands to pass ₩100 billion of annual sales on Olive Young, in 2023.
Olive Young gives a brand reach that no road-shop chain could match, and it is also the gatekeeper for shelf space, promotions and the ranking boards that drive Korean beauty trends.
Where It Sells Abroad: Japan, the US and Amazon
Clio's overseas business is meaningful but not dominant. The answer to "how much is overseas" depends on which table you read:
- Export sales (the business section): 41% of January–September 2026 sales, or ₩100.8 billion, against 59% domestic.
- Revenue by location (the separate-statement notes): ₩95.8 billion abroad out of ₩235.9 billion, about 41%, and down 2.9% from ₩98.7 billion a year earlier.
- Company IR, Q2 2026 (via Cosin Korea): overseas sales of ₩41.1 billion, or 47% of the quarter's consolidated revenue, against ₩45.7 billion (53%) at home. That split includes the sales of overseas subsidiaries, which is why it is higher.
By country, Hankyung reported the 2024 overseas mix as Japan 26%, North America 19%, Southeast Asia 18% and China 14%. In May 2025 a company official told the paper that Japan, the US and Vietnam were its strategic markets, with Europe and the Middle East as new offline targets.
The growth story is North America. Cosin Korea reported that Clio's North American sales rose 58% in Q2 2026 from a year earlier, "아마존 아이 카테고리 판매 호조와 오프라인 유통망 확대에 힘입어" (helped by strong sales in Amazon's eye category and wider offline distribution), and mentioned Clio's entry into Olive Young's US store. In China, the same report credited Goodal's green-tangerine (청귤) vitamin C line, sold mainly through Douyin.

The Numbers: Flat Sales, Much Higher Profit
In 2026 Clio's sales went nowhere and profit nearly tripled.
| Period (consolidated) | Revenue | Operating profit | Margin |
|---|---|---|---|
| FY2024 | ₩351.4bn ($263m) | ₩24.6bn ($18m) | 7.0% |
| FY2025 | ₩328.9bn ($246m) | ₩16.4bn ($12m) | 5.0% |
| Jan–Sep 2025 | ₩248.3bn | ₩9.4bn | 3.8% |
| Jan–Sep 2026 | ₩245.4bn ($184m) | ₩25.1bn ($19m) | 10.2% |
| Q2 2026 | ₩86.8bn ($65m) | ₩11.6bn ($9m) | 13.4% |
| Q3 2026 | ₩80.2bn ($60m) | ₩7.7bn ($6m) | 9.5% |
| Q3 2025 | ₩83.8bn | ₩4.7bn | 5.6% |
Sources: Q3 2026 quarterly report (annual and nine-month figures); Clio's DART preliminary results of 13 August 2026 (Q2) and 12 November 2026 (Q3, with Q3 2025 for comparison). Margins are EpicKor calculations.
2025 was a bad year. The first quarter of 2025 was an earnings shock. Hankyung, quoting a Hanwha Investment & Securities analyst, reported Q1 2025 revenue of ₩82.3 billion, down 11.4%, and operating profit of ₩1.1 billion, down 86.5%, with sales falling in the US (−33%), China (−25%) and Southeast Asia (−5%). The analyst blamed competition: "경쟁 심화로 전 채널 매출이 감소했다" (sales fell in every channel because of tougher competition). Hankyung added that the share price, at ₩15,450, was 65.67% below its post-listing high of ₩45,000 on 13 June 2024.
2026 is the recovery, but not through sales. Clio announced that Q2 2026 brought its highest-ever quarterly operating profit, operating margin and net profit. Revenue in that quarter was up only 6%. Cosin Korea's account of the Q2 results gives three reasons for the profit:
- Cheaper products to make relative to price. The cost-of-sales ratio fell from 54.0% to 48.6%.
- Less spent on selling. Selling and admin costs fell 3.6%, and their share of revenue from 41.7% to 38.0%.
- Less home shopping. Sales commissions fell 30.7% after Clio replaced live TV home-shopping broadcasts with cheaper "data broadcasts".
Q3 was softer than Q2. Revenue fell 7.6% from the second quarter and operating profit 34.1%, according to the 12 November preliminary disclosure, although Q3 operating profit was still up 62.2% on a year earlier. Q3 net profit, by contrast, was down 40% year on year at ₩3.3 billion, because of higher financial costs in the quarter.
The nine-month figures confirm the pattern. Gross profit rose to ₩121.5 billion from ₩117.7 billion on lower sales, and selling and admin costs fell 11% to ₩96.4 billion. Exports, meanwhile, slipped. That is why "record profit while exports stalled" is an accurate description of 2026 so far. Clio got leaner, not bigger.
The balance sheet is strong. At 30 September 2026 Clio had ₩129.7 billion of cash and ₩33.2 billion of short-term financial assets against total liabilities of ₩74.2 billion. Its only bond-type debt was about ₩7.4 billion of exchangeable bonds issued in early 2026. Hankyung called it "사실상 무차입 경영", effectively debt-free, in 2025.
Honest Counter-Points
A record quarter does not make Clio a safe bet. The concerns:
- Competition in its core categories. Lip sales fell from ₩72.2 billion in 2024 to ₩40.1 billion for the first nine months of 2026, and the 2025 slump was explicitly blamed on competition: "경쟁 심화로 전 채널 매출이 감소했다", in the Hanwha analyst's words quoted by Hankyung.
- Channel concentration. One customer, very likely Olive Young, is 38% of separate revenue and rising. A change in that chain's terms, promotions or shelf allocation would hit Clio harder than almost anything else.
- Overseas is not growing as a whole. North America is up strongly, but overseas revenue in the separate accounts was down 2.9% for the nine months. Clio is still mostly a Korean domestic business.
- The margin gains may not repeat. Cutting home shopping and selling costs is a one-time lever. Once those savings are banked, profit growth has to come from sales again.
- Governance. With more than 60% in one family's hands, minority shareholders have little say. The 2022 Dealsite reporting on board independence shows how that plays out.
- It is not a manufacturer. If you are a buyer looking for a Korean factory, Clio is the wrong door. Its products come from COSMAX, C&C International, Kolmar Korea and others.
How Clio Compares With Other K-Beauty Owners
Clio is older than nearly all the Korean beauty companies EpicKor has covered, and more makeup-focused.
- APR (Medicube) is a founder-led company too, but its founder holds a far smaller stake. See Who Owns Medicube?
- Goodai Global bought up brands such as Beauty of Joseon, TIRTIR and SKIN1004 instead of building them, the opposite of Clio's in-house approach. See Who Owns Beauty of Joseon?
- d'Alba Global is a skincare company with a much higher overseas share, about 72% in the first half of 2026. See Is d'Alba Korean or Italian?
- VT Cosmetics began as a different business altogether. See Who Makes VT Reedle Shot?
If you are buying CLIO's best-known product, our Korean cushion shade guide explains the 17/21/23 shade system and how CLIO's Kill Cover shades map against TIRTIR and HERA.
FAQ
Q: Is Clio a Korean brand?
A: Yes. CLIO belongs to Clio Cosmetics Co., Ltd. (주식회사 클리오), a Seoul company listed on KOSDAQ since November 2016. Its filings trace it back to Clio Sangsa, founded in 1993.
Q: Who owns Clio Cosmetics?
A: Founder and CEO Han Hyun-ok (한현옥) owns 48.57%. With her child Hong Myung-ha (11.81%) and spouse Hong Seok-ki (0.33%), the family held 60.71% on 31 December 2025, according to the FY2025 annual report filed on 23 March 2026. After the child's on-market purchases in 2026, the family total was 62.06% (large-holding report, 29 June 2026).
Q: Is Clio owned by Amorepacific or LG?
A: No. Clio is independent and founder-controlled. It is not an affiliate of any Korean conglomerate.
Q: Are Peripera and Goodal Korean?
A: Yes. Both are Clio Cosmetics brands. peripera is its younger, cheaper colour brand built around lip tints; Goodal is its skincare brand, known for the green-tangerine (청귤) vitamin C line.
Q: Where are Clio products made?
A: In Korea, by contract manufacturers. Clio has no factory. COSMAX is its largest supplier, followed by C&C International and Kolmar Korea.
Q: Is Kill Brow a separate brand?
A: No. Kill Brow is a CLIO brow product line, just as Kill Cover is its cushion and foundation line.
Q: How big is Clio?
A: Consolidated revenue was ₩328.9 billion (about $246 million) in 2025, with operating profit of ₩16.4 billion. For January to September 2026, revenue was ₩245.4 billion and operating profit ₩25.1 billion, already more than all of 2025.
Q: How much of Clio's business is overseas?
A: About 41% of January–September 2026 sales were exports, according to the Q3 report. Including overseas subsidiaries, the company's IR put overseas at 47% of revenue in Q2 2026. Japan and North America are its largest overseas markets.
Related Reading
- COSMAX Deep Dive 2026: The ODM Engine Behind Global K-Beauty — the factory that makes much of Clio's range.
- Who Owns Beauty of Joseon? Goodai Global — a very different way of owning K-beauty brands.
- Who Owns Medicube? APR and Its Founder's Stake — another founder-led listed beauty company.
- Is d'Alba Korean or Italian? — the same "is it Korean?" question for a brand with an Italian name.
- Korean Cushion Shades: 17 vs 21 vs 23 — the shopper's side of CLIO's Kill Cover cushion.
Sources
- Clio Cosmetics, Q3 2026 quarterly report (분기보고서), filed 13 November 2026 — DART receipt no. 20261113001150: business overview, brands, 1993 predecessor, product mix, unit prices, suppliers, domestic and export sales, sales channels, summary and consolidated financials, revenue by location, major customer, shareholders at 30 September 2026. dart.fss.or.kr
- Clio Cosmetics, FY2025 annual report (사업보고서), filed 23 March 2026 — DART receipt no. 20260323001466: largest shareholder and related parties at 31 December 2025, relationships, unchanged largest shareholder since founding, small-shareholder count, founder's career and birth month, board composition. dart.fss.or.kr
- Han Hyun-ok and special related parties, large-holding report (주식등의대량보유상황보고서), filed 29 June 2026 — DART receipt no. 20260629000530: family stake 60.71% to 62.06%, Hong Myung-ha's purchases, prices and funding, release of the 2019 gift-tax pledge. dart.fss.or.kr
- Clio Cosmetics, cash dividend decision (현금ㆍ현물배당결정), 13 February 2026 — DART receipt no. 20260213901845: ₩250 a share for 2025. dart.fss.or.kr
- Clio Cosmetics, preliminary consolidated results (연결재무제표기준영업(잠정)실적), Q2 2026 (13 August 2026, DART receipt 20260813900811) and Q3 2026 (12 November 2026, DART receipt 20261112900880). dart.fss.or.kr
- Cosin Korea, "클리오, 2분기 영업이익 116억원 '역대 최대' 달성", 14 August 2026: record claim, overseas share, North America growth, cost explanations
- Hankyung, "주가 5만원 가나 했더니…1억 넣었으면 3500만원 된 종목" (kicker: "32년 색조화장품 강자 클리오"), 17 May 2025: brand shares of 2024 sales, overseas country mix, shareholding split, free float, 2024 dividend, TRUE RX launch, Q1 2025 results and analyst comments
- Dealsite, "경영진 감시자로 '깐부' 내세운 클리오 한현옥 대표", 24 August 2022: National Pension Service votes, family stake above 66% at the time, Club Clio closures
- CJ Newsroom, "CJ올리브영, 첫 中企 '1000억 브랜드' 등장", 6 February 2024: CLIO and Round Lab as the first SME brands above ₩100 billion on Olive Young
- Clio Cosmetics English site, CEO message: brand list and "EVERY POUCH ONE CLIO"
- Sidae, "소비자 눈으로 경영… 일하는 여성엔 '든든한 언니'", 6 April 2012: reasons for starting her own brand
- Bank of Korea ECOS: KRW/USD rate of ₩1,335 on 17 November 2026
Last updated: 20 November 2026. Company figures, brands, suppliers, sales splits, shareholdings, the founder's career and the dividend are from Clio Cosmetics' DART filings (FY2025 annual report, Q3 2026 quarterly report, the 29 June 2026 large-holding report and preliminary results). The reasons behind the Q2 2026 profit jump and the overseas split for that quarter are as reported by Cosin Korea from the company's results. Brand shares and the overseas country mix are as reported by the Korean press. Percentages, margins and growth rates not quoted from a source are EpicKor calculations. The Amazon listing was checked on 20 November 2026 and can change. EpicKor has no commercial relationship with Clio Cosmetics, and nothing here is investment advice.
More Business Guides

Who Makes VT Reedle Shot? The Korean Laminator Company Behind VT Cosmetics
VT Cosmetics is Korean. Its owner, VT Co., Ltd. (브이티), began in 1986 as GMP, a laminating-machine maker in Paju. Cosmetics sales rose from ₩177bn in 2023 to ₩409bn in 2025, per DART. Who owns it, who makes it, and where the profit went.

Who Owns Numbuzin? BENOW, the Korean Company Behind fwee and the No.3 Serum
Numbuzin is Korean. The brand belongs to BENOW Inc. (비나우) in Seocho, Seoul, which also owns the makeup brand fwee. Its two largest shareholders hold 66.9%, per DART audit reports. Revenue reached ₩325 billion in 2025, 55% of it from outside Korea.

Who Owns SKIN1004? Craver Corporation, the Korean Company Behind the Centella Ampoule
SKIN1004 is Korean. Its maker, Craver Corporation (크레이버코퍼레이션) in Seoul, is controlled by Goodai Global through TM Beauty and a Japanese holding company, per DART filings. Revenue reached ₩678 billion in 2025, 83% of it from outside Korea.